(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 5.02% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.56%.
Albemarle's revenue in 2026 is $5,907,904,000.On average, 24 Wall Street analysts forecast ALB's revenue for 2026 to be $754,996,354,686, with the lowest ALB revenue forecast at $660,710,314,143, and the highest ALB revenue forecast at $916,899,292,890. On average, 22 Wall Street analysts forecast ALB's revenue for 2027 to be $761,368,627,764, with the lowest ALB revenue forecast at $596,279,553,021, and the highest ALB revenue forecast at $1,010,359,298,034.
In 2028, ALB is forecast to generate $819,427,115,808 in revenue, with the lowest revenue forecast at $587,547,178,803 and the highest revenue forecast at $1,113,849,733,023.